Compare IPHA & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPHA | HQI |
|---|---|---|
| Founded | 1999 | 2002 |
| Country | France | United States |
| Employees | 163 | 75000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 173.8M |
| IPO Year | N/A | 2008 |
| Metric | IPHA | HQI |
|---|---|---|
| Price | $1.85 | $12.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.75 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 128.4K | 15.3K |
| Earning Date | 03-26-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.08% |
| EPS Growth | N/A | ★ 73.08 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $30,640,000.00 |
| Revenue This Year | $180.36 | N/A |
| Revenue Next Year | N/A | $0.46 |
| P/E Ratio | ★ N/A | $112.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.18 | $7.38 |
| 52 Week High | $2.63 | $13.19 |
| Indicator | IPHA | HQI |
|---|---|---|
| Relative Strength Index (RSI) | 54.47 | 53.59 |
| Support Level | $1.72 | $9.81 |
| Resistance Level | $2.34 | $12.83 |
| Average True Range (ATR) | 0.21 | 0.77 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 40.77 | 46.58 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.